mobile header

AOI launches its Comprehensive Cancer Care Facility with an exclusive State-of-the-art Bone Marrow and Hematology Unit, in Vijayawada

Vijayawada, October 28, 2021: American Oncology Institute (AOI), South Asia’s leading chain of cancer hospitals, has launched its Comprehensive Cancer Care Facility with an exclusive state-of-the-art Bone Marrow and Hematology Unit in Vijayawada, Andhra Pradesh. AOI at Nagarjuna Campus is the third Facility of AOI in AP.

Dr. Jagprag Singh Gujral, Group CEO – South Asia, CTSI along with Dr. Kodali Jagan Mohan Rao – Managing Director – Nagarjuna Hospital and Dr. Vijay Kumar Vemuri – Group COO – CTSI inaugurated the unit.

Other dignitaries who graced the event were Dr.C.Nageswararao, Director General, Dr.PSIMS&RF, Dr.N.SubbaRao, Medical Director, AOI-NRI, Dr.Y.RajaRao, Ex. Chairman, APMedicalCouncil, Dr.RasikSanghvi, President, IMA-Vijayawada, Dr.K.Gopalakrishna, Managing Director, AayushHospitals, Vijayawada, Dr.K.Prasanth Kumar, Chairman, Prasanth Hospitals, Dr.G.Ramesh, Chairman, ANU Hospital, Dr.V.Naveen Kumar, COO Kamineni Hospitals.

American Oncology Institute is one of the Comprehensive Cancer Unit in Andhra Pradesh with a multidisciplinary team of Cancer Specialists, providing all the modalities of Medical Oncology, Haemato-Oncology, Radiation Oncology, and Cancer Surgeries under one roof based on the international treatment guidelines in cancer care.

AOI’s aim is to provide each patient with a personalized treatment plan tailored to meet their unique, changing needs– before, during, and after the transplant. AOI offers Minimally Invasive Techniques such as Laparoscopy in Surgical Oncology, Stereotactic Body Radiotherapy (SBRT) or Stereotactic Radiosurgery (SRS) procedures in Radiation Oncology, and Immunotherapy or Targeted Therapy in Medical Oncology.

The state-of-the-art BMT and Hematology Unit will cater to patients with complex blood disorders and blood cancers which include all kinds of anemia, marrow failure syndromes, coagulation disorders, acute and chronic leukemia, myelomas, lymphomas (Hodgkin’s and Non-Hodgkin’s), thalassemia, and various genetic disorders, etc.

On this occasion, Dr. Jagprag Singh Gujral, Group CEO- South Asia, CTSI said, “At American Oncology Institute, our vision is to build an evidence-based practice to meet the highest standards for trust, transparency, and technology while taking care of patient needs. With the launch of our new BMT and Hematology Unit in AP region we strive to deliver what’s best for our patients and improve the lives of the patients we serve.”

Dr. Vijay Kumar Vemuri, Group Chief Operating Officer, American Oncology Institute said, “Over the last few years, AOI has emerged as the most preferred cancer care hospital in various regions because of its differentiated approach in diagnosing and treating cancer. With best-in-class diagnostic modalities and treatment processes, protocols and standards, American Oncology Institute has been providing the best quality outcomes.”

“Bone marrow transplant and Hematology is a specialized field that requires experience, expertise, and teamwork between multiple specialties,” says, Dr. Rajesh Kota, Medical Director, American Oncology Institute. “The patients are treated using a comprehensive approach by full-fledged, UK trained Hematologist, Oncologists, Stem Cell Transplant Coordinators, ICU team, and Nurses”, he added.

Dr. Rajesh Mallik Gottipati, Hematologist and BMT Specialist, American Oncology Institute, said “At AOI, a wide range of treatments and medical procedures are available including stem cell collection, processing, cryopreservation/storage and infusion, BMT counseling, automatic and selective control system, air handling unit, etc.

“As part of our commitment to bringing world-class health care, we continuously provide the latest and most innovative technologies for the best and quick cancer recovery,” Mahender Reddy, COO – Andhra Region, American Oncology Institute, said. The hospital is equipped with ultramodern infrastructure and is supported by state-of-the-art laboratory and transfusion facilities to deliver International standards of cancer care.”

About American Oncology Institute:
American Oncology Institute (A unit of Cancer Treatment Services Hyderabad Pvt Ltd) is a wholly-owned subsidiary of CTSI (Mauritius) Ltd, which is owned & controlled by Varian Medical Systems, Inc (the ultimate holding company is Siemens Healthineers AG).

American Oncology Institute is a leading cancer care provider across South Asia. It operates a chain of cancer hospitals in multiple cities across India. American Oncology Institute was co-founded in 2006 by a group of physicians and industry experts, with decades of experience in University of Pittsburgh Medical College (UPMC), Pittsburgh, the USA in managing oncology practices, AOI brings US university-level medical care to underserved areas worldwide.

AOI was started with an aim to close the gap between standards of cancer care in South Asia and the US through transporting the rich lineage of its parent organization in offering Precision Cancer Care. AOI provides comprehensive cancer management that is powered by clinical excellence, world-class technology as well as international pathways and protocols for treatment planning and execution, providing never-before quality in cancer care across India and South Asia. Equipped with the world’s latest medical technology including True Beam Linear Accelerator, American Oncology Institute stands at the forefront of cancer care excellence.

Related Media